COMPOSITION PHARMACEUTIQUE COMPRENANT UN INHIBITEUR DE SGLT2, UN INHIBITEUR DE DPP-IV ET ÉVENTUELLEMENT UN AUTRE AGENT ANTI-DIABÈTE ET SES UTILISATIONS
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
